Skip to Content

M 515 (Mirtazapine 15 mg)

Pill with imprint M 515 is Beige, Round and has been identified as Mirtazapine 15 mg. It is supplied by Mylan Pharmaceuticals Inc..

Mirtazapine is used in the treatment of depression; major depressive disorder and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 515

Mirtazapine 15 mg M 515
Mirtazapine 15 mg M 515  Front
Mirtazapine 15 mg M 515  Back
Mirtazapine 15 mg M 515

Mirtazapine

Imprint:
M 515
Strength:
15 mg
Color:
Beige
Size:
7.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Tetracyclic antidepressants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC CodeLabeler / Repackager
00378-3515 Mylan Pharmaceuticals Inc.
51079-0086 UDL Laboratories Inc.
54569-5895 A-S Medication Solutions, LLC (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide